InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
2
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the complete record of transactions filed by KEYSER D JEFFREY, Director. Director active across 1 company, notably Lantern Pharma Inc.. Aggregated, 3 disclosures have been logged. Split: 2 buys · 0 sell. Total volume traded: €170k. Activity tracked since 24 July 2024. The latest transaction was disclosed on 12 May 2026 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations3 total
48,544 shares@ US$2.060.21% mcap50.0% of flowCommon stock, $0.001 par valueSEC:0001493152-26-023082
Ideal exit: 6 Feb 2027 (T+270)
48,544 shares@ US$2.060.21% mcap50.0% of flowCommon stock, $0.001 par valueSEC:0001493152-26-023082:0
Ideal exit: 6 Feb 2027 (T+270)
3,832 shares@ US$3.136.1% of flowCommon stockSEC:0001493152-24-029238:0
3 of 3 declarations
About KEYSER D JEFFREY
Jeffrey D. Keyser serves as a Board Member of Lantern Pharma Inc. He participates in the governance of the company by overseeing operations and contributing to strategic decision-making. His role is essential in ensuring compliance and transparency in the company's activities.
